Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
BMJ Open Qual ; 7(3): e000035, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30057948

RESUMO

Delivering high quality care in acute psychiatry requires a coordinated approach from a multidisciplinary team (MDT). Weekly ward rounds are an important forum for reviewing a patient's progress and developing a personalised care plan for the coming week. In general medicine, structured ward rounds and check lists have been shown to prevent omissions and improve patient safety; however, they are not widely used in psychiatry. At the Royal Edinburgh Hospital, the format of ward rounds differed between psychiatry wards and clinical teams, and care plans were not standardised. An audit in October 2015 found only 5% of acute psychiatric inpatients had a documented nursing care plan. It was agreed that a clear multidisciplinary care plan from the weekly ward round would be beneficial. A group of consultant psychiatrists identified seven key domains for ward round (Social needs, Community Mental Health Team liaison, Assessments required, Mental Health Act, Prescriptions: medication electroconvulsive therapy (ECT), T2/T3, Engagement with relatives and carers, Risk Assessment and Pass Plans). This was given the acronym SCAMPER. Following this, a clinical MDT on a paired male and female ward, developed and introduced a structured ward round sheet. Within 8 weeks this was being used for 100% of patients. It was subsequently introduced into three other acute adult psychiatry wards and the intensive psychiatric care unit. Staff feedback was sought verbally and via a questionnaire. This was positive. The form was widely accepted and staff felt it improved patient care and ward round quality.

2.
FP Essent ; 443: 11-5, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27092562

RESUMO

Appropriate screening for HIV infection is the cornerstone of HIV-related care. There have been several recent changes in testing technology and screening recommendations. The US Preventive Services Task Force recommends universal HIV screening at least once for adolescents and adults ages 15 to 65 years, and additional screening for patients at higher risk, although evidence is insufficient to determine optimum rescreening intervals. All pregnant women should be screened for HIV infection in the first trimester, and pregnant women at high risk should be screened again in the third trimester. The Centers for Disease Control and Prevention recommends use of an algorithm using fourth-generation tests for screening; this decreases the window period between infection and detection to as few as 14 days, thereby reducing the number of false-negative results. Home HIV testing kits, which require follow-up confirmatory testing, also are available. Clinicians should be aware of HIV-specific laws in their states, including those criminalizing HIV exposure and transmission. Thorough medical and laboratory evaluations are essential at initiation of care for patients with HIV infection, along with appropriate follow-up monitoring, as recommended in various guidelines.


Assuntos
Infecções por HIV/diagnóstico , Programas de Rastreamento/métodos , RNA Viral/sangue , Carga Viral , Adolescente , Adulto , Idoso , Algoritmos , Contagem de Linfócito CD4 , Direito Penal , Feminino , Anticorpos Anti-HIV/imunologia , Proteína do Núcleo p24 do HIV/imunologia , Infecções por HIV/sangue , Infecções por HIV/imunologia , HIV-1/imunologia , HIV-2/imunologia , Humanos , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Guias de Prática Clínica como Assunto , Gravidez , Kit de Reagentes para Diagnóstico , Medição de Risco , Fatores de Risco , Estados Unidos , Adulto Jovem
3.
FP Essent ; 443: 16-22, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27092563

RESUMO

Care of patients with HIV infection starts with diagnosis as soon as possible, preferably at or near the time of acute infection. Opportunistic infections, malignancies, and other conditions develop progressively over time, particularly in untreated patients. The AIDS-defining opportunistic infections most common in the United States include Pneumocystis jirovecii pneumonia, Candida esophagitis, toxoplasmic encephalitis, tuberculosis, disseminated Mycobacterium avium complex, cryptococcal meningitis, and cytomegalovirus retinitis. Specific prophylaxis regimens exist for several opportunistic infections, and effective antiretroviral therapy reduces the risk of most others. Other AIDS-defining conditions include wasting syndrome and HIV encephalopathy. AIDS-defining malignancies include Kaposi sarcoma, systemic non-Hodgkin lymphoma, primary central nervous system lymphoma, and invasive cervical cancer. Although not an AIDS-defining condition, anal cancer is common in patients with HIV infection. Other HIV-related conditions include thrombocytopenia, recurrent bacterial respiratory infections, HIV-associated nephropathy, and HIV-associated neurocognitive disorder.


Assuntos
Complexo AIDS Demência , Nefropatia Associada a AIDS , Infecções Oportunistas Relacionadas com a AIDS , Infecções por HIV , Neoplasias , Neoplasias do Ânus , Candidíase , Neoplasias do Sistema Nervoso Central , Comorbidade , Retinite por Citomegalovirus , Doenças do Esôfago , Feminino , Humanos , Linfoma , Linfoma não Hodgkin , Masculino , Infecção por Mycobacterium avium-intracellulare , Pneumonia por Pneumocystis , Sarcoma de Kaposi , Trombocitopenia , Toxoplasmose Cerebral , Tuberculose , Estados Unidos , Neoplasias do Colo do Útero
4.
FP Essent ; 443: 23-30, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27092564

RESUMO

The advent of combination antiretroviral drug regimens has transformed HIV infection from a fatal illness into a manageable chronic condition. All patients with HIV infection should be considered for antiretroviral therapy, regardless of CD4 count or HIV viral load, for individual benefit and to prevent HIV transmission. Antiretroviral drugs affect HIV in several ways: entry inhibitors block HIV entry into CD4 T cells; nucleotide and nucleoside reverse transcriptase inhibitors prevent reverse transcription from RNA to DNA via chain-terminating proteins; nonnucleoside reverse transcriptase inhibitors prevent reverse transcription through enzymatic inhibition; integrase strand transfer inhibitors block integration of viral DNA into cellular DNA; protease inhibitors block maturation and production of the virus. Current guidelines recommend six combination regimens for initial therapy. Five are based on tenofovir and emtricitabine; the other uses abacavir and lamivudine. Five include integrase strand transfer inhibitors. HIV specialists should assist with treating patients with complicated HIV infection, including patients with treatment-resistant HIV infection, coinfection with hepatitis B or C virus, pregnancy, childhood infections, severe opportunistic infections, complex drug interactions, significant drug toxicity, or comorbidities. Family physicians can treat most patients with HIV infection effectively by choosing appropriate treatment regimens, monitoring patients closely, and retaining patients in care.


Assuntos
Inibidores da Fusão de HIV/uso terapêutico , Infecções por HIV/tratamento farmacológico , Inibidores de Integrase de HIV/uso terapêutico , Inibidores da Protease de HIV/uso terapêutico , Inibidores da Transcriptase Reversa/uso terapêutico , Terapia Antirretroviral de Alta Atividade , Didesoxinucleosídeos/uso terapêutico , Combinação de Medicamentos , Quimioterapia Combinada , Emtricitabina/uso terapêutico , Humanos , Lamivudina/uso terapêutico , Tenofovir/uso terapêutico
5.
FP Essent ; 443: 31-42, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27092565

RESUMO

With the advent of antiretroviral therapy and improved access to care, the average life expectancy of patients with HIV infection receiving optimal treatment approaches that of patients in the general population. AIDS-related opportunistic infections and malignancies are no longer the primary issues; instead, traditional age- and lifestyle-related conditions are a growing concern. Patients with HIV infection are at higher risk of cardiovascular disease, diabetes, hypertension, and some non-AIDS-related cancers than patients in the general population. Family physicians need to be knowledgeable about screening for and managing chronic comorbid conditions as this population ages. Health maintenance, including appropriate vaccinations, prophylaxis against opportunistic infections, and routine screening for sexually transmitted infections, remains an important part of care. As HIV infection becomes a chronic condition, emerging strategies in prevention, including preexposure prophylaxis, fall within the scope of practice of the family physician.


Assuntos
Doenças Cardiovasculares/diagnóstico , Diabetes Mellitus/diagnóstico , Infecções por HIV/terapia , Hipertensão/diagnóstico , Neoplasias/diagnóstico , Atenção Primária à Saúde , Infecções Sexualmente Transmissíveis/diagnóstico , Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Infecções Oportunistas Relacionadas com a AIDS/prevenção & controle , Adulto , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/terapia , Doença Crônica , Comorbidade , Diabetes Mellitus/epidemiologia , Diabetes Mellitus/terapia , Detecção Precoce de Câncer , Infecções por HIV/epidemiologia , Hepatite Viral Humana/prevenção & controle , Humanos , Hipertensão/epidemiologia , Hipertensão/terapia , Vacinas contra Influenza/uso terapêutico , Influenza Humana/epidemiologia , Influenza Humana/prevenção & controle , Resistência à Insulina , Masculino , Programas de Rastreamento , Neoplasias/epidemiologia , Neoplasias/terapia , Infecções por Papillomavirus/epidemiologia , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/uso terapêutico , Infecções Sexualmente Transmissíveis/epidemiologia , Vacinas contra Hepatite Viral
6.
Acta Neurol Belg ; 111(3): 217-9, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22141286

RESUMO

Multiple CNS infections can coexist in advanced AIDS, but are most commonly reported in autopsy case studies. We describe the case of an HIV+ individual, who was first diagnosed with CNS toxoplasmosis, confirmed by brain biopsy. After initiation of combined anti-retroviral therapy (cART) and successful treatment of CNS toxoplasmosis, he developed worsening neurological symptoms and was subsequently diagnosed with progressive multifocal leukoencephalopathy. Retrospective analysis of the MRI scans indicated that PML was already present early on but was interpreted as edema associated with CNS toxoplasmosis. Clinicians should be aware that multiple pathologies may coexist in the brain of immunosuppressed individuals and that PML may develop and worsen despite the use of cART.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/diagnóstico , Coinfecção/diagnóstico , Diagnóstico Tardio , Leucoencefalopatia Multifocal Progressiva/diagnóstico , Toxoplasmose Cerebral/diagnóstico , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Adulto , Antirretrovirais/uso terapêutico , Antiprotozoários/uso terapêutico , Coinfecção/tratamento farmacológico , Evolução Fatal , Humanos , Leucoencefalopatia Multifocal Progressiva/tratamento farmacológico , Imageamento por Ressonância Magnética , Masculino
7.
J Med Chem ; 50(13): 2967-80, 2007 Jun 28.
Artigo em Inglês | MEDLINE | ID: mdl-17536795

RESUMO

There remains a high unmet medical need for a safe oral therapy for thrombotic disorders. The serine protease factor Xa (fXa), with its central role in the coagulation cascade, is among the more promising targets for anticoagulant therapy and has been the subject of intensive drug discovery efforts. Investigation of a hit from high-throughput screening identified a series of thiophene-substituted anthranilamides as potent nonamidine fXa inhibitors. Lead optimization by incorporation of hydrophilic groups led to the discovery of compounds with picomolar inhibitory potency and micromolar in vitro anticoagulant activity. Based on their high potency, selectivity, oral pharmacokinetics, and efficacy in a rat venous stasis model of thrombosis, compounds ZK 814048 (10b), ZK 810388 (13a), and ZK 813039 (17m) were advanced into development.


Assuntos
Amidas/síntese química , Aminopiridinas/síntese química , Anticoagulantes/síntese química , Inibidores do Fator Xa , Tiofenos/síntese química , ortoaminobenzoatos/síntese química , Amidas/farmacocinética , Amidas/farmacologia , Aminopiridinas/farmacocinética , Aminopiridinas/farmacologia , Animais , Anticoagulantes/farmacocinética , Anticoagulantes/farmacologia , Cristalografia por Raios X , Cães , Humanos , Técnicas In Vitro , Masculino , Modelos Moleculares , Tempo de Protrombina , Ratos , Ratos Wistar , Relação Estrutura-Atividade , Tiofenos/farmacocinética , Tiofenos/farmacologia , Trombose Venosa/tratamento farmacológico , ortoaminobenzoatos/farmacocinética , ortoaminobenzoatos/farmacologia
9.
Ann Thorac Surg ; 75(5): 1635-7, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12735596

RESUMO

Splenic abscess is a rare clinical entity that is most commonly associated with infective endocarditis. Valve replacement in the setting of an unaddressed splenic abscess is associated with a high incidence of prosthetic valve infection and death. We describe 2 patients with infective endocarditis and splenic abscess treated by laparoscopic splenectomy followed by valve replacement.


Assuntos
Abscesso/cirurgia , Endocardite Bacteriana/cirurgia , Implante de Prótese de Valva Cardíaca , Laparoscopia , Esplenectomia , Esplenopatias/cirurgia , Abscesso/complicações , Adulto , Idoso , Humanos , Masculino , Esplenopatias/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...